Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV

医疗补助数据作为队列研究的补充,用于调查老年艾滋病毒感染者的癌症

基本信息

  • 批准号:
    10132275
  • 负责人:
  • 金额:
    $ 67.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-24 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT Non-AIDS defining cancers (NADCs) are projected to account for 89% of all cancers among people living with HIV (PLWH) by 2030, with the vast majority diagnosed among older PLWH. This shift is concerning because, as compared to people without HIV, PLWH reportedly have higher cancer-specific mortality for several NADCs, and higher overall mortality after diagnosis of the most common NADCs. The explanation for higher mortality among PLWH after a NADC is likely multifactorial and, at present, not fully understood. Given approximately 45% of PLWH are 50 years, with 84% of those between 50 and 64, it is critical to understand the intersection between HIV, NADCs, and healthy aging in this population. To inform the development of effective NADC prevention and treatment strategies for the aging PLWH population, it is important to be able to disentangle the influence of HIV from the socio-behavioral factors associated HIV acquisition. To do this, a comparison group with a comparable burden of risk factors, socioeconomic status, and access to care is needed. Approximately 40% of PLWH in the US are covered by Medicaid. Medicaid beneficiaries are a diverse population, and include a comparison group for PLWH with similar risk factor burden and access to care. The Medicaid population is an important complement to existing HIV resources, including those that (1) capture cancer incidence but not downstream events, such as the HIV-Cancer Match cohort, (2) include rich cohort data, but have limited specific types of cancer cases to allow for examining race and sex differences, like the NA-ACCORD, and (3) other claims-based cohorts which capture, important, but different segments of the HIV and general population, including SEER-Medicare. We propose to assess claims for more than 5 million Medicaid beneficiaries 50 years old from 14 states between 2001 and 2017, in the modern era of antiretroviral therapy, to: (1) quantify the age-, race/ethnicity-, and sex- specific incidence of NADCs by cancer type among PLWH (2) evaluate the association between HIV-infection and NADC-specific treatment-related outcomes, (3) evaluate the association between NADC-specific diagnosis and new AIDS-defining illnesses and retention in HIV care, and (4) evaluate whether a diagnosis of both HIV and NADC, by cancer type, is associated with a higher risk of age-related outcomes as compared a diagnosis of HIV or NADC alone. Findings from this study will inform how aging in the presence of HIV affects the risk and consequences of non-AIDS defining cancers, and impacts HIV care and age-related outcomes among older adults. Importantly, we will evaluate our aims among a low-income, diverse population of men and women 50 years old with a comparison population with comparable risk factors and access to care.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corinne E. Joshu其他文献

Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000–2020
在2000 - 2020年期间,在美国艾滋病毒诊所招收的艾滋病毒的男性接受前列腺癌筛查的决定因素
  • DOI:
    10.1016/j.ypmed.2024.108000
  • 发表时间:
    2024-07-01
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Filip Pirsl;Jeanne C. Keruly;Richard D. Moore;Bryan Lau;Corinne E. Joshu
  • 通讯作者:
    Corinne E. Joshu
Guidelines:Colorectal cancer/Colonoscopy surveillance/The elderly and stopping rules
指南:结直肠癌/结肠镜监测/老年人和停止规则
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jacqueline E. Rudolph;Keri L. Calkins;Xueer Zhang;Yiyi Zhou;Xiaoqiang Xu;Eryka L Wentz;Corinne E. Joshu;Bryan Lau
  • 通讯作者:
    Bryan Lau
Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001–2015 in 14 states
2001 年至 2015 年 14 个州的医疗补助受益人中感染和未感染 HIV 的前列腺癌发病率
  • DOI:
    10.1101/2024.05.24.24307676
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Filip Pirsl;Keri L. Calkins;Jacqueline E. Rudolph;Eryka L Wentz;Xiaoqiang Xu;Bryan Lau;Corinne E. Joshu
  • 通讯作者:
    Corinne E. Joshu
Receipt of prostate-specific antigen test in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
2001 年至 2015 年,14 个州的感染和未感染 HIV 的医疗补助受益人接受了前列腺特异性抗原检测。
  • DOI:
    10.1089/aid.2023.0142
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Filip Pirsl;Keri L. Calkins;Jacqueline E. Rudolph;Eryka L Wentz;Xiaoqiang Xu;Yiyi Zhou;Bryan Lau;Corinne E. Joshu
  • 通讯作者:
    Corinne E. Joshu
Subsequent risk of cancer among adults with peripheral artery disease in the community: The atherosclerosis risk in communities (ARIC) study
社区中患有外周动脉疾病的成年人患癌症的后续风险:社区动脉粥样硬化风险(ARIC)研究
  • DOI:
    10.1016/j.ijcard.2024.132577
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Shoichiro Nohara;Yejin Mok;Jeremy R. Van't Hof;Maya Salameh;Corinne E. Joshu;Elizabeth A. Platz;Roberta Florido;Kunihiro Matsushita
  • 通讯作者:
    Kunihiro Matsushita

Corinne E. Joshu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corinne E. Joshu', 18)}}的其他基金

At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies
HIV 和 COVID-19 的交叉点:医疗补助数据作为队列研究的补充
  • 批准号:
    10642852
  • 财政年份:
    2022
  • 资助金额:
    $ 67.71万
  • 项目类别:
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies
HIV 和 COVID-19 的交叉点:医疗补助数据作为队列研究的补充
  • 批准号:
    10548472
  • 财政年份:
    2022
  • 资助金额:
    $ 67.71万
  • 项目类别:
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
医疗补助数据作为队列研究的补充,用于调查老年艾滋病毒感染者的癌症
  • 批准号:
    10580704
  • 财政年份:
    2020
  • 资助金额:
    $ 67.71万
  • 项目类别:
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
医疗补助数据作为队列研究的补充,用于调查老年艾滋病毒感染者的癌症
  • 批准号:
    10364673
  • 财政年份:
    2020
  • 资助金额:
    $ 67.71万
  • 项目类别:
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
医疗补助数据作为队列研究的补充,用于调查老年艾滋病毒感染者的癌症
  • 批准号:
    10013582
  • 财政年份:
    2020
  • 资助金额:
    $ 67.71万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 67.71万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 67.71万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 67.71万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 67.71万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 67.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了